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Abstract
The apelinergic system, comprised of apelin and its G
protein-coupled receptor (APJ; APLNR as given in MGI
Database), is expressed within key regions of the central
nervous system associated with arginine vasopressin (AVP)
synthesis and release as well as in structures involved in the
control of drinking behaviour, including the magnocellular
neurones of the hypothalamus, circumventricular organs, and
the pituitary gland. This localisation is indicative of a possible
functional role in ﬂuid homeostasis. We investigated a role for
APJ in the regulation ofﬂuid balance using mice deﬁcient for
the receptor. Male APJ wild-type and knockout (APJ
K/K)
mice were housed in metabolic cages to allow determination
of water intake and urine volume and osmolality. When
provided with free access to water, APJ
K/K mice drank
signiﬁcantly less than wild-types, while their urine volume
and osmolality did not differ. Water deprivation for 24 h
signiﬁcantly reduced urine volume and increased osmolality
in wild-type but not in APJ
K/K mice. Baseline plasma AVP
concentration increased comparably in both wild-type and
APJ
K/K mice following dehydration; however, APJ
K/K
mice were unable to concentrate their urine to the same
extent as wild-type mice in response to the V2 agonist
desmopressin. Analysis of c-fos (Fos as given in MGI Database)
mRNA expression in response to dehydration showed
attenuation of expression within the subfornical organ,
accentuated expression in the paraventricular nucleus, but
no differences in expression in the supraoptic nucleus nor
median pre-optic nucleus in APJ
K/K mice compared with
wild-type. These ﬁndings demonstrate a physiological role for
APJ in mechanisms of water intake and ﬂuid retention and
suggest an anti-diuretic effect of apelin in vivo.
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Introduction
Apelin, a novel 36 amino acid peptide originally isolated from
extracts of bovine stomach (Tatemoto et al. 1998), mediates its
actions through the G protein-coupled (GPCR) apelin
receptor (APJ; APLNR as given in the MGI Database).
Inadditiontoapelin-36,other possibleisoformsofthepeptide,
including the pyroglutamyl form of apelin-13 (pGlu-apelin-
13) and apelin-17, have been discovered in rat hypothalamic
extracts and plasma (De Mota et al. 2004). Synthetic peptides
pGlu-apelin-13 and apelin-17 bind to APJand exhibit greater
biological activity than the parent peptide on the human
(Habata et al. 1999, Zou et al. 2000, Medhurst et al. 2003)o r
rat APJ (De Mota et al. 2000). In recent years cDNA
sequences for human, rat, and mouse APJ have been
determined (O’Dowd et al. 1993, Devic et al. 1999, O’Carroll
et al. 2000), with closest identity (31%) found to the
angiotensin II (AngII) receptor, type AT1a.
The apelinergic system has a widespread but selective
expression in the central nervous system (CNS) implicating
it in the regulation of a number of physiological processes
(Lee et al. 2000, O’Carroll et al. 2000, Reaux et al. 2002).
Signiﬁcantly, APJ mRNA expression and apelin immuno-
reactivity are present in magnocellular neurones of the
hypothalamic paraventricular (PVN) and supraoptic nuclei
(SON), sites that control the hypothalamic–neurohypophysial
system (HNS), the pituitary gland and within the circumven-
tricular organs (CVOs, structures involved in the control of
drinking behaviour; De Mota et al. 2000, Reaux et al. 2001,
2002, Brailoiu et al. 2002, O’Carroll & Lolait 2003).
The key CNS site integrating neuroendocrine adjustments
to water homeostasis is the hypothalamic PVN. Arginine
vasopressin (AVP), a major neurohypophysial hormone
within the HNS, is synthesised in magnocellular neurones
of the hypothalamic PVN and SON (Burbach et al. 2001)
that project through the median eminence to the neurohypo-
physis and form the hypothalamo-neurohypophysial tract
(Antunes-Rodrigues et al. 2004). The HNS is the primary
source of AVP and the related peptide oxytocin (OT) that are
secreted into the systemic circulation from neurones
terminating in the posterior pituitary. These magnocellular
neurones are themselves innervated by osmoresponsive
neurones originating in the CVOs, including the organum
vasculosum of the lamina terminalis (OVLT), subfornical
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pre-optic area. Elevated plasma osmolality and/or decreased
plasma volume, as seen during periods of water deprivation,
stimulate activity within the CVOs–HNS resulting in the
secretion of AVP into the circulation (Antunes-Rodrigues
et al. 2004, McKinley et al. 2004). In the kidney plasma AVP
acting at the AVP V2 receptor increases renal collecting cell
permeability via increased translocation, synthesis, and
expression of the water channel aquaporin-2, so promoting
water retention (Knepper & Inoue 1997).
Previous studies have demonstrated expression of APJ to be
differentially regulated in rats in response to ﬂuid deprivation
and increased dietary salt within brain areas such as the PVN
and SON, indicating a role for the apelinergic system in ﬂuid
homeostasis (O’Carroll & Lolait 2003). In addition, in the
neurohypophysial axis, the physiological effects of apelin
appear to be mediated by AVP but inconsistent effects have
been reported. There is evidence that apelin acts to
counteract AVP actions through regulation of AVP neurone
activity and AVP secretion (Reaux et al. 2001, De Mota et al.
2004, Reaux-Le Goazigo et al. 2004, Azizi et al. 2008).
Additionally, a study on water deprivation showed a
signiﬁcant increase in both the number and labelling intensity
of magnocellular apelin-immunoreactive cells in the rat SON
and PVN that were signiﬁcantly reduced after chronic
exposure to the AVP V1 receptor antagonist MeT–
AVP (1-b-mercapto-b,b-cyclopentamethylene-propionyl)-
2-(O-methyl)Tyr,Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2;
Reaux-Le Goazigo et al. 2004). Repeated i.c.v. injections of
AVP resulted in an increase in SON and PVN apelin-
immunoreactivity, an effect that could be attenuated by i.c.v.
pretreatment with the AVP V1 antagonist, indicating that this
effect, like the dehydration-inducted effects, is mediated
through AVP V1 receptors. Exogenously administered apelin
also reduced the amount of circulating AVP and stimulated
diuresis (De Mota et al. 2004). Contrary to these studies are
reports that in vitro apelin-13 signiﬁcantly stimulated AVP
release from rat hypothalamic explants (Taheri et al. 2002),
while apelin-13 administration onto SON neurones via
microdialysis increased the ﬁring rates of AVP cells (Tobin
et al. 2008). In this latter study, apelin inhibited both basal and
stimulated somatodendritic release of AVP. Apelin and APJ
have therefore been linked to the regulation of body ﬂuid
homeostasis, in particular to a role regulating the anti-diuretic
action of AVP (Lee et al. 2000, Reaux et al. 2001, 2002,
Taheri et al. 2002, De Mota et al. 2004, Reaux-Le Goazigo
et al. 2004, Azizi et al. 2008), but many contradictions exist
that remain to be resolved.
Similarly, a role for the apelinergic system in thirst and
drinking behaviour has been proposed, although currently
reports also differ with regard to its contribution. In water
replete (WR) animals an immediate, short lived (30 min) but
signiﬁcant increase in water intake following i.p. or i.c.v.
apelin injection (Lee et al. 2000, Taheri et al. 2002) has
been reported, whereas other studies found apelin to
signiﬁcantly reduce water intake up to 12 h post i.c.v.
injection (Clarke et al. 2009) or to have no effect (Reaux et al.
2001, Mitra et al. 2006). Additionally, studies in water
deprived (WD) animals have shown regulatory actions of
apelin on ﬂuid homeostasis with i.c.v. apelin reducing (Reaux
et al. 2001) or having no effect (Mitra et al. 2006) on water
intake. However, in mice lacking the apelin gene the
dehydration-induced drinking response was comparable
with that of wild-type mice suggesting that apelin does not
have an apparent role in water intake (Kuba et al. 2007).
A peripheral increase in apelin (i.p.) appeared to activate
neurones in the CVOs and hypothalamus consistent with the
involvement of the apelinergic system in ﬂuid homeostasis
(Takayama et al. 2007).
To date, the majority of studies have used exogenous
administration of either apelin or AVP to elucidate the role of
the apelinergic system in body ﬂuid homeostasis. In this study,
we have used APJ knockout (KO) mice to investigate the
involvement of APJ in body ﬂuid regulation during normal
physiological conditions and water deprivation.
Materials and Methods
Animals
Adult male littermates (a mix of the C57BL/6J and
129X1/SvJ strains) of crosses using mice heterozygous for
the APJ mutation (Deltagen, San Carlos, CA, USA) were
bred and maintained on site. Prior to the experimental
period, animals were housed under controlled light con-
ditions (12 h light:12 h darkness cycle, lights on at 0700 h)
and temperature (21G2 8C) with free access to standard lab
chow and water. All procedures were conducted in
accordance with the Animal Scientiﬁc Procedures Act
(1986), the United Kingdom and the appropriate University
of Bristol Ethical Review Process.
Offspring were genotyped at weaning using PCR analysis
of DNA isolated from tail clips. Genomic templates were used
for PCR analysis with primers directed to the APJ coding
sequence (Primers 1, 2, 6, and 7) and to the neomycin
resistance gene (contained in the disrupted targeting vector
construct; Primers 3, 4, and 5) in a buffer mix: 10!Hot Start
buffer (Continental Lab Products, Northampton, UK; 1 ml),
dNTP mix (Perkin Elmer; 1.6 ml), primer mix (for Primers 3
and 4: 0.2 mlo f1 0 mM of each primer; for all other
Primers: 1.0 mlo f4 mM of each primer), CLP Hot start
polymerase (0.2 ml), and dH2O (to a ﬁnal volume of 10 ml).
Oligonucleotide primers used were as follows: Primer
1( 5 0-TGATGGTTACAACTACTATGGGGCT-30) and
Primer 2 (50-GTCAAACTCCCGGTAGGTATAAGTG-30)
were used to amplify the wild-type allele, Primer 3
(50-AGAGGCTATTCGGCTATGACTG-30) and Primer 4
(50-TTCGTCCAGATCATCCTGATC-30) were used to
amplify the recombinant allele and Primer 5 (50-GGG
TGGGATTAGATAAATGCCTGCTCT-30), which was
unique to the neomycin cassette, was used in a ‘multiplex’
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CAGTCTGAATG-30), and 7 (50-CACAGTGGCAAAGT-
CACCACAAAGG-30) to detect both wild-type and targeted
alleles. Negative controls contained no template DNA. PCR
conditions were 96 8C for 15 min, followed by 35 cycles of
96 8C for 10 s, 60 8C for 30 s, 68 8C for 90 s, with a ﬁnal
extension of 68 8C for 7 min.
Measurement of ﬂuid intake, urine output, and osmolality
Mice (8–14 weeks-old wild-type nZ16; APJ KO (APJ
K/K)
nZ16) were individually housed in metabolic cages
(Techniplast, Varese, Italy) to examine the effect of APJ
deletion on ﬂuid intake, urine output, and osmolality.
Animals were weighed and allowed to acclimatise to the
cage for 48 h with free access to crushed lab chow and water.
All subsequent measurements and procedureswereconducted
between 0900 and 1030 h. Mice were given a measured
amount (50 ml) of water, and spontaneously voided urine was
collected under mineral oil (200 ml; Sigma) for 24 h. Basal
water intake, urine output, and osmolality (freezing point
depression; Roebling Osmometer, Berlin, Germany) were
measured. The animals were then divided into two groups,
one of which was deprived of drinking water for 24 h (WD;
nZ8), while the second group continued to have free access
to water (WR; nZ8) after which water intake, urine output,
and osmolality were again measured. Mice were killed by
decapitation and trunk blood collected for measurement of
plasma AVP, while brains were rapidly dissected out, frozen
on dry ice, and stored at K80 8C.
Effect of AVP V2- receptor agonist desmopressin
To examine the renal responses of APJ
K/K mice to AVP, the
effect of endogenous AVP was mimicked by exogenous
administration of an AVP-V2 receptor agonist, desmopressin
(dDAVP; Sigma). Mice (nZ5–6) were housed in metabolic
cages as described above and, following the appropriate
period of acclimatisation, baseline urine samples were
collected by bladder massage. Mice were then injected
subcutaneously with 1 mg/kg dDAVPor vehicle (0.9% saline)
and water bottles were removed. Urine samples were
collected from the cage 4 h after injection and by bladder
massage 4 h after injection. Urine samples were centrifuged
brieﬂy to remove debris and osmolality measured by freezing
point depression.
Measurement of plasma AVP
Trunk blood was collected in chilled tubes containing EDTA
(1 mg/ml blood; Sigma) and aprotinin (500 KIU/ml blood;
Sigma). Samples were kept on ice and centrifuged at 1690 g
for 20 min at 4 8C. Plasma was stored at K80 8C until assay.
Plasma AVP concentration was determined by speciﬁc RIA
following extraction with heat-activated LiChroprep Si60
(Merck; Landgraf et al. 1995). The level of sensitivity was
0.1 pg/sample; cross-reactivity of the polyclonal anti-AVP
antibody with structurally related peptides including lysine
vasopressin and OT was !0.7%. Intra- and inter-assay
coefﬁcients of variation were in 6–9 and 9–12% ranges
respectively; all plasma samples to be compared were assayed
in the same run.
In situ hybridisation histochemistry
Sections (12 mm) of tissue were cut, thaw-mounted onto
polysine-coated slides (VWR, Lutterworth, UK), and stored
at K80 8C until hybridisation. Speciﬁc riboprobes were used
to look at neurone activity within the CVOs/HNS and to
conﬁrm genotype. All
35S riboprobes were generated by
PCR using 129SV genomic DNA as template. For the
mouse, c-fos (Fos as given in MGI Database primers(upstream
50-ACAGATCTGCCTGCAAGATCC-30; downstream
50-GTGAGCTCAGGGAGTCGGAGGA-30) corresponding
to 2164–2679 bp of a mouse c-fos (Fos as given in MGI
Database) gene (Genbank Accession number J00370) were
used to generate a 516 bp product. The primers contain the
recognition sequences for the restriction endonucleases BglII
and SacI. For the mouse AVP,
35S riboprobe primers
(upstream 50-TGCTGCAGCGACGAGAGCTGCGT-30;
downstream 50-GCAAGCTTATTTTCCATGCTGT-30)
corresponding to bp 2966–3392 of a mouse AVP-neurophy-
sin II gene (Genbank Accession number M88354) were used
to generate a 224 bp product. The primers contain the
recognition sequences for the restriction endonucleases PstI
and HindIII. For the mouse APJ,
35S riboprobe primers
(upstream 50-GCCCGAATTCACTTCATTCAGCAC-
CATGGAAGAT-30; downstream 50-GTCAGGATCCCG-
GTAGGTATAAGTGGCCCACAGT-30) corresponding to
bp 256–549 of a mouse apelin receptor cDNA (Genbank
Accession number NM 011784) were used to generate a
293 bp product. The primers contain the recognition
sequences for the restriction endonucleases EcoRI and
BamHI. Primer restriction endonuclease sites allowed
subcloning into pGEM4Z (Promega), and sense and antisense
probes were generated using T7 and SP6 polymerases (c-fos
antisense: linearised with HindIII and generated with SP6
polymerase; sense: linearised with EcoRI and generated with
T7 polymerase; AVP and APJ antisense: linearised with
EcoRI and generated with T7 polymerase; sense: linearised
with HindIII and generated with SP6 polymerase) with
35S-UTP (Perkin Elmer) and the MAXIscript in vitro
transcription kit (Ambion, Austin, TX, USA). The integrity
of each probe was veriﬁed by DNA sequencing.
Hybridisation was carried out as previously described
(http://intramural.nimh.nih.gov/lcmr/snge/Protocols/ISHH/
ISHH.html). Slides were exposed to Amersham Hyperﬁlm
MP ﬁlm for 8 weeks for APJ (reﬂecting the low abundance
of APJ mRNA), 2 days for AVP, and 5 weeks for c-fos at
room temperature with appropriate
14C-labeled standards
(Amersham). No speciﬁc hybridisation was detected with
sense probes.
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In order to compare peripheral tissue morphology of wild-
type and APJ
K/K mice, a hematoxylin and eosin (H&E) stain
was carried out on 4 mm thick sections of parafﬁn-embedded,
Bouin’s (Sigma) ﬁxed organs, including the pituitary gland,
adrenal gland, kidney, lung, heart, ovary and testis. Tissue
morphology was assessed using light microscopy.
Statistical analysis
Water intake and urine output were calculated as ‘ml per 24 h
per 20 g body weight’. All data are expressed as meanGS.E.M.
Any differences between WR wild-type and WR APJ
K/K
mice were determined by Student’s (unpaired two-tailed)
t-test. Effects of genotype and treatment were determined by
two-way ANOVA with repeated measures and subsequent
post hoc tests. Plasma AVP RIA data are expressed as pg/ml,
givenasmeanGS.E.M.,andcomparedusingtwo-wayANOVA.
For in situ hybridisation histochemistry (ISHH) data, analysis
of the autoradiographic images of probe bound and visualised
on ﬁlm was carried out using NIH Image software (Rasband,
version 1.22; http://rsb.info.nih.gov/nih-image/) run on an
Apple Macintosh IICi using 2–4 sections from each animal.
ISHH was carried out on tissue sections cut from regions of
interest (SFO, MnPO, SON, PVN). These regions were
delineated by comparison of APJ
K/K images to wild-type
control images cut at the same tissue level. Foreach image, the
region of interest was selected and its mean optical density
determined. Using the standard curve, a representative value
for that areawas obtained; datawere expressed as a percentage
of the mean for the control group (wild-type/WR) and this
was used for statistical analysis. All values to be statistically
compared were processed in the same assay to avoid inter-
assay variability. ISHH data are expressed as a percentage of
the mean for the control group (wild-type/WR), and
compared using two-way ANOVA and post hoc tests.
Statistical comparisons were made using GraphPad Prism
software. P!0.05 was considered statistically signiﬁcant.
Results
Characteristics of APJ
K/K mice
Mice lacking the APJ gene were bred from APJ heterozygous
matings.Absenceofthegeneinhomozygousmutantmicewas
determined by PCR (Fig. 1A). Analysis of progeny genotypes
at weaning showed 6% to be homologous for the disrupted
allele,28%tobewild-typeand66%tobeheterozygousfor the
APJ mutation, indicating a loss of homozygous mutants.
However, homozygous survivors were viable and fertile and,
besides a signiﬁcantly lower body weight than wild-type
littermates (APJ
K/K 26.71G0.68 g, wild-type 28.44
G0.50 g, P!0.05), showed no obviously visible phenotype.
Histological analysis of H&E-stained sections from the
pituitary gland, adrenal gland, kidney and lung (Fig. 1B) and
heart, ovary and testis (data not shown), did not reveal any
apparent morphological differences in APJ
K/K mice
compared with wild-type littermates. Representative ISHH
autoradiographic images showing APJ mRNA expression in
sections of heart and PVN from wild-type and APJ
K/K mice
are shown in Fig. 1C. No APJ mRNA expression was
observed in APJ
K/K mice. Expression of APJ mRNA by
ISHH was not detected in other peripheral APJ
K/K tissues
including the lung and kidney (data not shown).
Role of APJ in ﬂuid homeostasis in mice with free access to
drinking water
Under normal conditions (WR) drinking behaviour,
measured as intake in 24 h, was signiﬁcantly less in APJ
K/K
mice compared with wild-type (wild-type 5.3G0.5 ml/24 h
per 20 g; APJ
K/K 3.9G0.4 ml/24 h per 20 g; P!0.05).
Spontaneously voided urine volume (wild-type 1.00
G0.12 ml/24 h per 20 g; APJ
K/K 1.02G0.14 ml/24 h per
20 g) and urine osmolality (wild-type 3008
G165 mOsmol/kgH2O; APJ
K/K 3169G252 mOsmol/
kgH2O) were comparable between genotypes (Fig. 2).
Effect of water deprivation on ﬂuid homeostasis in wild-type
and APJ
K/K mice
Water deprivation for 24 h signiﬁcantly decreased urine
volume in wild-type mice (0.954G0.20 vs 0.375
G0.09 ml/24 h per 20 g; P!0.01) but not in APJ
K/K
mice (0.891G0.18 vs 0.668G0.1 5m l / 2 4h p e r 2 0g ;
PO0.05; Fig. 3). Similarly, urine osmolality was signiﬁcantly
increased in wild-type (3284G246 vs 5229G389 mOsmol/
kgH2O; P!0.05) but not in APJ
K/K mice (3649G351
vs 4610G674 mOsmol/kgH2O; PO0.05).
Plasma AVP
In WR mice, plasma AVP levels tended to be lower in
APJ
K/K mice (23.3G6.3p g / m l ) t h a n i n w i l d - t y p e
(39.5G7.8 pg/ml), although this did not achieve statistical
signiﬁcance (PZ0.138). Following 24 h WD, there were
comparable increases in AVP concentration in both
genotypes (wild-type 57.7G3.5 pg/ml versus APJ
K/K
52.9G2.9 pg/ml; Fig. 4).
Effect of dDAVP on urine osmolality
Urine osmolalities prior to dDAVP administration were
comparable between wild-type and APJ
K/K mice. Admin-
istration of dDAVP signiﬁcantly increased urine osmolality
both in wild-type (3278G258–4635G244 mOsmol/
kgH2O; P!0.01) and APJ
K/K mice (2575G322–3590
G151 mOsmol/kgH2O; P!0.05), however the dDAVP-
induced increase in APJ
K/K mice was signiﬁcantlyattenuated
compared with wild-type (APJ
K/K 3590G151 versus wild-
type 4635G244 mOsmol/kgH2O; P!0.05).
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of wild-type and APJ
K/K mice
To determine the effect of WD on the regulation of HNS
gene expression, ISHH was performed with speciﬁc ribo-
probes to detect changes in c-fos and AVP gene expression
within the MnPO, SFO, SON, and PVN, all major
components of the HNS. In WR mice, low levels of
c-fos mRNA expression were found in all regions studied
that were statistically comparable between genotypes.
WD signiﬁcantly increased c-fos mRNA expression in
all regions, and to a similar extent in the MnPO (wild-
type 528.9G73.1%; APJ
K/K 395.2G43.7%) and SON
(wild-type 270.8G32.2%; APJ
K/K 349.7G24.4%) of both
genotypes. However, c-fos mRNA expression was signi-
ﬁcantly attenuated in the SFO and accentuated in the PVN
of APJ
K/K mice versus wild-type (SFO, APJ
K/K 377.8
G61.1% versus wild-type 981.3G193.7% P!0.001; PVN,
APJ
K/K 254.6G14.2% versus wild-type 186.5G18.0%
P!0.05; Fig. 5).
Figure 1 (A) Representative PCR of DNA extracted from tail clips from weaned pups. Image
shows wild-type, heterozygous (het), and APJ knockout (
K/K) genotypes. DNAwas isolated from
tail tips and three reactions carried out for each sample: a, primers 1 and 2 to detect endogenous
APJ; b, primers 3 and 4 to detect recombinant allele; and c, primers 5, 6, and 7 a multiplex
reaction to detect both endogenous and targeted genes. (B) Comparable histology (H&E) in
sections of pituitary gland, adrenal gland, kidney, and lung of wild-type and APJ
K/K mice.
Scale barsZ500 mm; a, anterior pituitary; c, cortex; i, intermediate lobe of pituitary; m, medulla;
p, posterior pituitary. (C) Representative ISHH autoradiographic images showing APJ mRNA
expression in sections of heart and PVN from wild-type ((i) and (iv)) and APJ
K/K ((ii) and (v)) mice.
No APJ mRNA expression was observed in the APJ
K/K mice. No speciﬁc labeling was seen in
thewild-typecontrolheartsectionusinga
35S-labeledsense-strandRNAcontrolprobe(iii).a,atria;
v, ventricle; 3V, third ventricle.
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K/K
WR mice did not differ, but signiﬁcantly higher levels
were found in the PVN of APJ
K/K mice (APJ
K/K 127.3
G7.4% versus wild-type 100.0G10.3%; t-test P!0.05,
Fig. 6). WD for 24 h increased levels comparably in both
groups in the SON, but only in the wild-type PVN. The
already elevated AVP mRNA levels in the PVN of APJ
K/K
mice did not respond further to the dehydration stimulus.
Discussion
ThisistheﬁrststudytouseAPJ-deﬁcientmicetodeterminethe
role of the apelinergic system in ﬂuid homeostasis. We have
shown abnormal water metabolism in APJ
K/K mice, mani-
fested by a change in drinking behaviour and in the ability to
concentrate urine. Under normal conditions, drinking
behaviour was signiﬁcantly reduced in mice lacking APJ,
while other indices of ﬂuid homeostasis, i.e. voided urine
volume and urine osmolality remained unaltered. In addition,
our results demonstrate that during periods of osmotic stress
induced by dehydration the expected water deprivation-
associated decrease in spontaneously voided urine volume and
increase in urine osmolality did not occur in APJ
K/K mice.
This defect did not appear to be due to altered regulation of
AVP secretion into the circulation but may involve disrupted
CVO and/or hypothalamic neuroendocrine expression as
wellasimpairedAVPreceptor-activatedprocessesinthekidney
in APJ
K/K mice. This study demonstrates a major physio-
logical role for APJ in the regulation of water intake and
ﬂuid retention.
APJ
K/K mice were bred from heterozygous crosses and
there were no apparent morphological differences in major
organsoftheKOmousecomparedwithwild-typelittermates.
These ﬁndings are in accordance with other reports of
comparable histology between wild-type and APJ
K/K mice
and are consistent with reports of comparable systolic blood
pressure and heart rate in APJ
K/K and wild-type mice (Ishida
et al. 2004). APJ
K/K mice, however, showed a variable
phenotype with a loss of homozygous mutants. Surviving
APJ
K/K mice had a signiﬁcantly lower body weight than
wild-type littermates that may reﬂect the diuretic phenotype
of these mutant mice, but showed no other obviously visible
phenotype. Reduced body weight in APJ
K/K mice is also
consistent with a report of chronic i.c.v. apelin administration
stimulating weight gain (Valle et al. 2008), but apelin’s precise
role in feeding behaviour remains to be resolved. Partial
lethality has been previouslyobserved in KO mousemodels of
otherGPCRsexpressedinthehypothalamusand/or pituitary,
such as the corticosterone releasing hormone receptor 1
(Smith et al. 1998, Timpl et al. 1998). The cause of this
lethality is as yet unknown and work is ongoing within our
group to explain the variable phenotype.
Figure 2 Fluid homeostasis in water replete wild-type (ﬁlled bars)
and APJ
K/K (open bars) mice. Drinking behaviour (A) was
signiﬁcantly attenuated in APJ
K/K mice compared with wild-
type when measured over 24 h, however, neither urine volume
(B) nor urine osmolality (C) differed between the genotypes. Data
are meanGS.E.M., nZ16, results of t-test *P!0.5.
Figure 3 Effects of water deprivation on urine volume and urine
osmolality. Mice were housed in metabolic cages and urine volume
collected after 24 h with water (WR) followed by 24 h without
water (WD). (A) WD signiﬁcantly decreased spontaneously voided
urine volume in wild-type (solid line) but not APJ
K/K (dotted line)
mice compared with WR. (B) WD signiﬁcantly increased urine
osmolality in wild-type (solid line) but not APJ
K/K (dotted line)
mice. Data are meanGS.E.M., nZ8, results of two-way repeated
measures ANOVA with Bonferroni post hoc test, ns, not signiﬁcant;
CP!0.05,
CCP!0.01 WD versus WR.
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system present in the hypothalamus where the apelinergic
system is involved in ﬂuid metabolism as dehydration was
shown to be associated with a signiﬁcant increase in APJ
mRNA expression in the SON and PVN (O’Carroll & Lolait
2003). Speciﬁcally, involvement with the vasopressinergic
system has been proposed (De Mota et al. 2004, Reaux-Le
Goazigo et al. 2004, Azizi et al. 2008). The ﬁrst apelin/APJ
localisation studies provided clues that apelin may regulate
vasopressinergic neurones activity. Apelin and APJ mRNA
and protein are all highly expressed in the PVN and SON
(Lee et al. 2000, O’Carroll et al. 2000, Reaux et al. 2002), and
APJ mRNA and apelin protein are co-localised with AVP in
both these nuclei (Reauxet al. 2001, O’Carroll & Lolait 2003,
Reaux-Le Goazigo et al.2 0 0 4 ). In addition, apelin
immunoreactivity is found along the hypothalamo-neurohy-
pophysial tract, in the internal zone of the median eminence
and in the posterior pituitary (Reaux et al. 2001, Brailoiu et al.
2002) suggesting an involvement in the control of water
balance. Effective ﬂuid homeostasis requires the rapid
secretion of AVP from the posterior pituitary into the general
circulation in response to various signals, including elevated
plasma osmolality, decreased extracellular ﬂuid volume and
increased AngII concentration (Antunes-Rodrigues et al.
2004). In this study, we have shown plasma AVP levels tended
to be lower in APJ
K/K mice than in wild-type controls under
normal conditions, consistent with a recent study showing
activation of AVP-neurones in the SON following adminis-
tration of apelin directly onto the exposed ventral glial lamina
of virgin female rats (Tobin et al. 2008). A dissociation
between the excitatory effect of apelin on AVP cell body
activity in vivo (implying increased AVP secretion from the
pituitary) and its inhibitory effect on somatodendritic AVP
release from isolated rat SON in vitro was shown, indicating
differential regulation of AVP release by apelin (Tobin et al.
2008). However, conﬂicting results have been shown in
lactating rats (De Mota et al. 2004) where an inverse
relationship between plasma apelin and AVP concentrations
was also reported. These effects may be dependent on the
physiological conditions of the animals, as AVP levels are
known to be elevated in lactating animals (Poulain et al. 1977),
or on the ongoing electrical activity of vasopressinergic cells
(Tobin et al. 2008).
We also observed a decrease in water intake by APJ
K/K
mice in this study, consistent with the lower plasma AVP
levels found in these mice and compatible with ﬁndings from
other groups ofincreaseddrinking behaviour following apelin
administration in the rat (Lee et al. 2000, Taheri et al. 2002),
but contrary to reports of apelin-13 inhibition of dehy-
dration-induced water intake (Reaux et al. 2001) and of
unaltered drinking behaviour in another APJ
K/K mouse line
(Ishida et al. 2004). Inconsistent ﬁndings with regard to
drinking behaviour may be due to differences in models used,
species or strain of rat (Lee et al. 2000, Reaux et al. 2001,
Taheri et al. 2002, Ishida et al. 2004, Mitra et al. 2006, Clarke
et al. 2009). The contrasting ﬁndings on the role of the
apelinergic system in drinking behaviour may also reﬂect the
activityat distinct populations of APJ, for example i.c.v. apelin
maymanifest adirecteffectat central APJpopulationswhereas
peripheral administration may modulate different functions
that are dependent on regional tissue site expression.
We then investigated the role of APJ in the regulation of
water balance during water deprivation when endogenous
levels of AVP are increased. Neurones in the SON respond
electrophysiologically, functionally, and morphologically to
osmotic perturbations (Dyball & Pountney 1973, Hatton et al.
1978, Bourque & Renaud 1984), and magnocellular
neuroendocrine cells in this region produce the majority
Figure 4 Plasma arginine vasopressin (AVP) concentration in wild-
type (ﬁlled bars) and APJ
K/K (open bars) water replete (WR 24)
mice and water deprived (WD 24) for 24 h. Data are meanGS.E.M.,
nZ6–8, results of two-way ANOVA show signiﬁcant comparable
increases in both genotypes following water deprivation (P!0.001).
Figure 5 Effect of water deprivation (WD) on expression of c-fos
mRNA in the MnPO, SFO, SON, and PVN. Expression of c-fos
mRNA was negligible in water replete (WR) wild-type (ﬁlled bars)
and APJ
K/K (open bars) mice. WD caused comparable increases in
c-fos mRNA in the MnPO and SON of wild-type and APJ
K/K mice,
however, the WD-induced signiﬁcant increase in c-fos mRNA
expression was signiﬁcantly reduced in the SFO of APJ
K/K mice
compared with wild-type, while in the PVN c-fos expression was
accentuated in APJ
K/K mice. The graph shows expression of c-fos
mRNA calculated as a percentage of wild-type/WR in the MnPO
(nZ3), SFO (nZ3), SON (nZ4–5), and PVN (nZ4–6). Data are
meanGS.E.M. of 2–4 images per animal and were analyzed using
two-way ANOVA and Bonferroni post hoc tests: *P!0.05,
***P!0.001 wild-type versus APJ
K/K;
CCP!0.01,
CCCP!0.001
WR versus WD.
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Rodrigues et al. 2004). Hyperosmotic and hypovolemic
stimulation increase the secretion of AVP and decrease
peptide content and immunoreactivity in the SON and
PVN (De Mota et al. 2004, Reaux-Le Goazigo et al. 2004).
We show that while water deprivation signiﬁcantly decreased
urine volume and increased urine osmolality in wild-type
controls, APJ
K/K mice were unable to concentrate their
urine to the same extent. This defect in water homeostasis did
not appear to be due to an inability of these animals to
increase plasma AVP levels as comparable increases were seen
in both genotypes following water deprivation, suggesting the
presence of an intact central AVP system in APJ
K/K mice.
Thus, factors other than central interactions between the
apelinergic and vasopressinergic systems may contribute to
apelinergic regulation of ﬂuid homeostasis. However, our
data contrast with other studies in which an increase in
diuresis is seen after apelin administration to lactating female
rats (De Mota et al. 2004, Hus-Citharel et al. 2008). As with
drinking behaviour, these differences may be due to the
physiological conditions of the animals.
As the defect in water metabolism seen in APJ
K/K mice
did not appear to be due to altered AVP neurosecretory
function, we investigated the possibility of a defect in renal
mechanisms in the mutant mice. Pronounced APJ and apelin
gene expression occur within peripheral tissues as well as
w i t h i nt h eC N S .B o t ha p e l i na n dAPJ mRNA have
previously been detected in the rat kidney associated with
glomeruli in the cortex, in cells of the vasa recta in the inner
stripe of the outer medulla, along the nephron including
the collecting ducts and in glomerular arterioles (Hosoya
et al. 2000, Lee et al. 2000, O’Carroll et al. 2000, Kawamata
et al. 2001, Medhurst et al. 2003, Hus-Citharel et al. 2008).
Using RT-PCR, apelin and APJ mRNA have also been
identiﬁed in mouse kidney (Medhurst et al. 2003). The strong
expression of APJ mRNA in the kidney suggests an
involvement of peripheral aspects of the apelinergic system
in the regulation of ﬂuid homeostasis. To determine whether
the defect observed in APJ
K/K mice may be due to a role of
APJ in regulating renal V2 receptors, the renal responses of
APJ
K/K mice to the AVP V2 receptor agonist dDAVP were
examined. Peripheral administration of dDAVP induced an
increase in urine osmolality indicative of increased ﬂuid
retention in APJ
K/K mice; however, this increase was not as
great as that seen in wild-type mice indicating an attenuation
of V2 receptor-associated pathways in APJ
K/K mice.
In the HNS, the physiological effects of apelin appear to be
mediated via AVP, perhaps by a direct action on APJ-
containing vasopressinergic PVN neurones (O’Carroll &
Lolait 2003). To determine whether central APJ receptors are
essential for AVP neuronal function, we investigated the
neurosecretory system under basal and osmotically stimulated
conditions. Increased expression of the immediate early gene
c-fos can be used as a marker of neuronal activation to identify
central nuclei involved in mediating stress responses (Wilson
et al. 2002) and was used in this study, alongside AVP mRNA
levels, as an index of activity in regions involved in the central
regulation of water homeostasis including the PVN, SON,
MnPO, and SFO. AVP release from the magnocellular
neurones during periods of osmotic stress is under the control
of various aspects of the lamina terminals (McKinley et al.
2004). Neurones originating in the SFO, MnPO, and OVLT
have direct efferent connections to the magnocellular SON
and PVN, in addition there is a high degree of inter-
connectivity between these regions forming a complex
osmoregulatory unit (Bourque et al. 1994). As expected,
low levels of c-fos mRNA expression were seen in the SON,
PVN, MnPO, and SFO of both wild-type and APJ
K/K WR
mice. Neuronal activation, using dehydration as a stimulus,
was seen as an increase in c-fos mRNA levels in all regions.
However, this response was attenuated in the SFO of APJ
K/K
mice, suggesting that APJ is required for dehydration-induced
signaling in this key structure involved in the regulation of
body ﬂuid balance. An accentuated c-fos response was seen in
the PVN of APJ
K/K mice, indicative of increased activity
compared with wild-type. However, in this instance it was
not possible to distinguish whether this speciﬁc increase
originated from magnocellular or parvocellular neurones so it
remains unclear as to the extent that this change might be
connected to ﬂuid metabolism. Interestingly, vasopressinergic
activity within the PVN was affected in APJ
K/K mice as AVP
mRNA levels in the PVN of these mice were elevated under
basal conditions but failed to respond to the dehydration
stimulus implying disruption of vasopressinergic systems in
the absence of APJ. APJ activity in the SFO, PVN, and other
brain regions may also be inﬂuenced either directly or
Figure 6 Expression of arginine vasopressin (AVP) mRNA in the
PVN and SON of wild-type (ﬁlled bars) and APJ
K/K (open bars)
mice housed in metabolic cages with (WR) or without (WD) free
access to drinking water for 24 h. The graph shows expression of
AVP mRNA calculated as a percentage of wild-type/WR in the SON
(nZ4–5) and PVN (nZ4). Data are meanGS.E.M. of 2–4 images per
animal, result of t-test to compare basal AVP mRNA expression
*P!0.05; comparisons between genotypes and treatment groups
were made using two-way ANOVA and Bonferroni post hoc test,
CP!0.05,
CCP!0.01,
CCCP!0.001 WR versus WD.
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apelin/APJ acting in an autocrine, paracrine, or neuromodu-
latory manner.
We observed that under normal conditions with free access
to drinking water, APJ
K/K mice drank less than, but excreted
comparable amounts of urine as, wild-type controls. As
plasma AVP levels tended to be lower in WR APJ
K/K mice
than in controls, it is tempting to speculate that removal of
APJ has created a modiﬁed adipsic diabetes insipidus-like
phenotype, a condition characterised clinically by the failure
to generate the sensation of thirst in conjunction with
hypotonic polyuria due to AVP deﬁciency (Crowley et al.
2007). Loss of thirst leads to failure to respond to diuresis with
appropriate ﬂuid intake and to the development of
hypernatremia (Crowley et al. 2007). Although not possible
to measure in this study due to small plasmavolumes, it would
be interesting to determine plasma osmolality and sodium
concentrations in the APJ
K/K mice. Recently, apelin has
been identiﬁed in adipocytes and pancreatic islets and
implicated in insulin-sensitive pathophysiologies, while
plasma apelin concentrations have been found to be reduced
in newly diagnosed type 2 diabetes mellitus (Boucher et al.
2005, Erdem et al. 2008).
In addition to involvement with vasopressinergic systems,
apelin and APJ have also been linked to the renin–angiotensin
system. In another APJ-deﬁcient model, APJ
K/K mice
displayed an enhanced vasopressor response to systemic
AngII, suggesting a counter-regulatory action of apelin on
AngII (Ishida et al. 2004). Additionally, apelin has been
reported to regulate glomerular hemodynamic function in the
rat kidney (Hus-Citharel et al. 2008). Circulating AngII
activates the HNS and stimulates thirst and ﬂuid retention via
receptors located in the CVOs and subsequent release of AVP
(Antunes-Rodrigues et al. 2004, McKinley et al. 2004). Mice
lacking the AngII AT1a
K/K receptor have increased water
intake, increasedurine output, and decreased urine osmolality
compared with controls under WR conditions and exhibit a
deﬁcit in their ability to concentrate urine in response to
water deprivation (Oliverio et al. 2000). Increased activity
within the PVN, measured by both c-fos-immunoreactivity
and AVP mRNA expression, in AT1a
K/K mice following
water deprivation further highlights the complexity of
ﬂuid metabolism (Morris et al. 2001). Despite the SFO and
MnPO being key sites of AngII activity during ﬂuid
metabolism and AVP secretion there was no signiﬁcant effect
on cellular activity within these regions in AT1a
K/K mice
(Morris et al. 2001). Emerging data thus indicate opposing
roles for the apelinergic and renin–angiotensin systems
(Hus-Citharel et al. 2008).
In conclusion, our study is an important step towards
deﬁning the physiological role of APJ in neurophyophysial
function using APJ deﬁcient mice. We have shown abnormal
water metabolism in APJ
K/K mice, possibly as a result of
altered central neuroendocrine expression and disruption
of the central AVP response to osmotic stimulus, as well as
impaired AVP receptor-activated processes in the kidney.
Our data demonstrate a physiological role for APJ in central
and peripheral mechanisms of water intake and ﬂuid retention
and suggest a novel anti-diuretic effect of apelin in vivo.
While a targeted approach for gene knockdown would
possibly circumvent the confounding effects found in global
KO models, suitable tissue- or brain-region-speciﬁc Cre lines
that would enable construction of relevant conditional
APJ–KOs are not available and there is a paucity of
APJ-selective ligands with which to explore the physiological
role of APJ. The APJ
K/K mice should provide a useful model
to investigate the role of apelin in other aspects of
hypothalamic function.
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